checkAd

     138  0 Kommentare Livongo and Dexcom Partner to Integrate Dexcom’s G6 Continuous Glucose Monitoring System into Livongo’s Applied Health Signals Platform - Seite 2

    “Together, Dexcom and Livongo provide the opportunity for people with diabetes to easily access the leading technology and insights they need to stay healthy,” said Kevin Sayer, Chairman, President and Chief Executive Officer of Dexcom. “Through a careful combination of clinical expertise, data science, and human coaching, the combined solution offers our users an even greater ability to understand themselves, their conditions, and what they need to get and stay healthy.”

    As of September 30, 2019, Livongo currently has more than 770 clients, including more than 20 percent of Fortune 500 companies, four of the top seven health plans, and two of the nation’s largest pharmacy benefit managers as partners. A 2019 study in collaboration with Eli Lilly and Company demonstrated that Livongo for Diabetes Members were more empowered and less distressed in diabetes self-management, when compared to non-Members. A separate 2019 Journal of Medical Economics study found that the Livongo for Diabetes program delivered an $88 per member monthly reduction in medical spending for Livongo Members and that employers experienced a positive return on investment in one year1.

    About Dexcom, Inc.
    DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes

    About Livongo
    Livongo offers a platform to care for the whole person and empowers people with chronic conditions to live better and healthier lives, beginning with diabetes and now including hypertension, weight management, diabetes prevention, and behavioral health. Livongo pioneered the category of Applied Health Signals to offer Members clinically-based insights that make it easier to stay healthy. Livongo’s team of data scientists aggregate and interpret substantial amounts of health data and information to create actionable, personalized and timely health signals delivered to Livongo Members exactly when and where they need them. The Livongo approach delivers better clinical and financial outcomes while creating a different and better experience for people with chronic conditions. For more information, visit: www.livongo.com or engage with Livongo on LinkedIn or Twitter.

    Seite 2 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Livongo and Dexcom Partner to Integrate Dexcom’s G6 Continuous Glucose Monitoring System into Livongo’s Applied Health Signals Platform - Seite 2 Dexcom CGM to become a core part of Livongo’s solution for delivering personalized health insights and improved clinical outcomes to people with DiabetesMOUNTAIN VIEW, Calif. and SAN DIEGO, Jan. 13, 2020 (GLOBE NEWSWIRE) - Livongo (Nasdaq: LVGO), …